Page last updated: 2024-11-04

sb 206553 and Seizures

sb 206553 has been researched along with Seizures in 1 studies

SB 206553: a high-affinity 5-HT(2C/2B) antagonist; structure given in first source

Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Upton, N1
Stean, T1
Middlemiss, D1
Blackburn, T1
Kennett, G1

Other Studies

1 other study available for sb 206553 and Seizures

ArticleYear
Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents.
    European journal of pharmacology, 1998, Oct-16, Volume: 359, Issue:1

    Topics: Animals; Drug Interactions; Electric Stimulation; Indoles; Male; Mice; Pentylenetetrazole; Pyridines

1998